Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: POLYCYTHEMIA VERA, . Treffer: 14
2023
Koschmieder, S; Isfort, S; Wolf, D; Heidel, FH; Hochhaus, A; Schafhausen, P; Griesshammer, M; Wolleschak, D; Platzbecker, U; Dohner, K; Jost, PJ; Parmentier, S; Schaich, M; von Bubnoff, N; Stegelmann, F; Maurer, A; Crysandt, M; Gezer, D; Kortmann, M; Franklin, J; Frank, J; Hellmich, M; Brummendorf, TH
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
ANN HEMATOL. 2023;
Doi: 10.1007/s00277-022-05080-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Buxhofer-Ausch, V; Heibl, S; Sliwa, T; Beham-Schmid, C; Wolf, D; Geissler, K; Krauth, MT; Krippl, P; Petzer, A; Wölfler, A; Melchardt, T; Gisslinger, H
Austrian recommendations for the management of essential thrombocythemia.
Wien Klin Wochenschr. 2021; 133(1-2):52-61
Doi: 10.1007/s00508-020-01761-3
Web of Science
PubMed
FullText
FullText_MUG
2018
Burgstaller, S; Buxhofer-Ausch, V; Sliwa, T; Beham-Schmid, C; Gastl, G; Geissler, K; Melchardt, T; Krauth, M; Krippl, P; Petzer, A; Rumpold, H; Wölfler, A; Gisslinger, H
Austrian recommendations for the management of polycythemia vera.
Wien Klin Wochenschr. 2018; 130(17-18):535-542
Doi: 10.1007/s00508-018-1359-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jakovic, L; Gotic, M; Gisslinger, H; Soldatovic, I; Sefer, D; Tirnanic, M; Lekovic, D; Jovanovic, MP; Schalling, M; Gisslinger, B; Beham-Schmid, C; Simonitsch-Klupp, I; Thiele, J
The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.
Ann Hematol. 2018; 97(9):1581-1590
Doi: 10.1007/s00277-018-3344-3
Web of Science
PubMed
FullText
FullText_MUG
Krauth, MT; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Keil, F; Krippl, P; Melchardt, T; Petzer, A; Rumpold, H; Sliwa, T; Wöhrer, S; Wölfler, A; Gisslinger, H
Ruxolitinib therapy for myelofibrosis in Austria : Consensus on therapy management.
WIEN KLIN WOCHENSCHR. 2018; 130(17-18): 495-504.
Doi: 10.1007/s00508-018-1365-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Jud, P; Hafner, F; Gary, T; Ghanim, L; Lipp, R; Brodmann, M
Intra-arterial thrombolysis of digital artery occlusions in a patient with polycythemia vera.
Vasa. 2017; 46(1):64-66
Doi: 10.1024/0301-1526/a000586
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sliwa, T; Beham-Schmid, C; Burgstaller, S; Buxhofer-Ausch, V; Gastl, G; Geissler, K; Krauth, M; Krippl, P; Lang, A; Petzer, A; Wöhrer, S; Wölfler, A; Gisslinger, H
Austrian recommendations for the management of primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis: an expert statement.
Wien Klin Wochenschr. 2017; 129(9-10):293-302
Doi: 10.1007/s00508-016-1120-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Gisslinger, H; Jeryczynski, G; Gisslinger, B; Wölfler, A; Burgstaller, S; Buxhofer-Ausch, V; Schalling, M; Krauth, MT; Schiefer, AI; Kornauth, C; Simonitsch-Klupp, I; Beham-Schmid, C; Müllauer, L; Thiele, J
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria.
Leukemia. 2016; 30(5):1126-1132
Doi: 10.1038/leu.2015.360
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kalmar, PI; Leithner, A; Ehall, R; Portugaller, RH
Is Embolization an Effective Treatment for Recurrent Hemorrhage After Hip or Knee Arthroplasty?
Clin Orthop Relat Res. 2016; 474(1):267-271
Doi: 10.1007/s11999-015-4476-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Vianello, F; Cella, G; Osto, E; Ballin, A; Famoso, G; Tellatin, S; Iliceto, S; Cucchini, U; Saggiorato, G; Omenetto, E; Tona, F
Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: the missing piece in the puzzle of their increased cardiovascular risk?
Am J Hematol. 2015; 90(2):109-13
Doi: 10.1002/ajh.23881
Web of Science
PubMed
FullText
FullText_MUG
2014
Vytrva, N; Stacher, E; Regitnig, P; Zinke-Cerwenka, W; Hojas, S; Hubmann, E; Porwit, A; Bjorkholm, M; Hoefler, G; Beham-Schmid, C
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Arch Pathol Lab Med. 2014; 138(9):1203-1209
Doi: 10.5858/arpa.2013-0018-OA
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Will, B; Siddiqi, T; Alberich Jordà, M; Shimamura, T; Luptakova, K; Staber, PB; Costa, DB; Steidl, U; Tenen, DG; Kobayashi, S
Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells.
Blood. 2010; 115(14):2901-2909
Doi: 10.1182/blood-2009-03-209544
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1987
Ludwig, H; Linkesch, W; Gisslinger, H; Fritz, E; Sinzinger, H; Radaszkiewicz, T; Chott, A; Flener, R; Micksche, M
Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.
Cancer Immunol Immunother. 1987; 25(3):266-273
Doi: 10.1007/BF00199157
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1979
Fereberger, W; Robier, FP; Sailer, S
A contribution to the cytostatic long-term chemotherapy of polycythemia vera (author's transl)
Blut. 1979; 39(6):399-403
Doi: 10.1007/BF01008660
Web of Science
PubMed
FullText
FullText_MUG